|
|
| 45.73 |  -0.41 / -0.89% |
Data as of 3:59pm ET | Day’s Change |
| 45.72 | -0.01 / -0.02% |
Volume: 48.6K |
| New Lifetime High Today: DexCom (DXCM) Mar 06 / TheStreet.com | DexCom Beats, Sees Narrower Q4 Loss - Analyst Blog Feb 25 / Zacks.com |
| Is DexCom (DXCM) a Great Growth Stock? - Tale of the Tape Mar 04 / Zacks.com |
| Previous close | 46.14 |
| Today’s open | 45.98 |
| Day’s range | 45.38 - 47.56 |
| Volume | 1,626,436 |
| Average volume (3 months) | 794,479 |
| Market cap | $3.4B |
| Dividend yield | -- |
| Earnings growth (last year) | +46.84% |
| Earnings growth (this year) | +75.51% |
| Earnings growth (next 5 years) | +32.50% |
| Revenue growth (last year) | +60.16% |
| P/E ratio | NM |
| Price/Sales | 15.74 |
| Price/Book | 39.78 |
| Today’s change | Today’s % change | |
|---|---|---|
| WSTWest Pharmaceutical ... | -0.75 | -1.62% |
| MRMindray Medical Inte... | +1.07 | +3.40% |
| PODDInsulet Corp | -0.29 | -0.60% |
| GMEDGlobus Medical Inc | -0.09 | -0.34% |
| Next reporting date | May 7, 2014 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $160.0M |
| Annual profit (last year) | -$29.8M |
| Net profit margin | -18.63% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Terry H. Gregg |
President, Chief Operating Officer & Director Kevin Ronald Sayer |
Corporate headquarters San Diego, California |
.
